These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35111661)

  • 1. DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma.
    Guo Y; Li Y; Li J; Tao W; Dong W
    Front Oncol; 2021; 11():629521. PubMed ID: 35111661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An independently validated survival nomogram for lower-grade glioma.
    Gittleman H; Sloan AE; Barnholtz-Sloan JS
    Neuro Oncol; 2020 May; 22(5):665-674. PubMed ID: 31621885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and Validation of a 5 m6A RNA Methylation Regulatory Gene Prognostic Model in Low-Grade Glioma.
    Bai Z; Wang X; Zhang Z
    Front Genet; 2022; 13():655169. PubMed ID: 35281815
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.
    Zhao J; Liu Z; Zheng X; Gao H; Li L
    Front Genet; 2021; 12():753680. PubMed ID: 34819946
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery.
    Yin X; Li M; He Z
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):234. PubMed ID: 37919061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a novel survival prediction model for newly diagnosed lower-grade gliomas.
    Zhu Q; Liang Y; Fan Z; Liu Y; Zhou C; Zhang H; He L; Li T; Yang J; Zhou Y; Wang J; Wang L
    Neurosurg Focus; 2022 Apr; 52(4):E13. PubMed ID: 35364578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
    Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
    Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prognostic Nomogram Model Based on mRNA Expression of DNA Methylation-Driven Genes for Gastric Cancer.
    Chen Z; Liu B; Yi M; Qiu H; Yuan X
    Front Oncol; 2020; 10():584733. PubMed ID: 33330065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ARL9 and its methylation in low-grade glioma.
    Tan Y; Zhang S; Xiao Q; Wang J; Zhao K; Liu W; Huang K; Tian W; Niu H; Lei T; Shu K
    Genomics; 2020 Nov; 112(6):4808-4816. PubMed ID: 32882327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of four immune-related genes in lower-grade gliomas: a biomarker discovery study.
    Wang S; Wang Z; Liu Z; Wu J
    Front Genet; 2024; 15():1403587. PubMed ID: 39192888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes.
    Li J; Wang J; Liu D; Tao C; Zhao J; Wang W
    Front Immunol; 2022; 13():1018942. PubMed ID: 36341390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.
    Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH
    BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative extension of telomeres related prognostic model to predict survival in lower grade glioma.
    Cai Y; Guo H; Zhou J; Zhu G; Qu H; Liu L; Shi T; Ge S; Qu Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13575-13589. PubMed ID: 37515613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma.
    Han C; He Y; Chen L; Wang J; Jiao S; Xia X; Li G; Yao S
    Onco Targets Ther; 2020; 13():7243-7255. PubMed ID: 32801753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.